Common Name |
Clobetasol
Description |
Clobetasol is only found in individuals that have used or taken this drug. It is a derivative of prednisolone with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than fluocinonide, it is used topically in treatment of psoriasis but may cause marked adrenocortical suppression. [PubChem]The precise mechanism of the antiinflammatory activity of topical steroids in the treatment of steroid-responsive dermatoses, in general, is uncertain. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postliated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Initially, however, clobetasol, like other corticosteroids, bind to the glucocorticoid receptor, which complexes, enteres the cell nucleus and modifies genetic transcription (transrepression/transactivation).
Structure |
MOLSDF3D-SDFPDBSMILESInChI View 3D Structure
Synonyms |
Value |
Source |
(11beta,16beta)-21-chloro-9-fluoro-11,17-Dihydroxy-16-methylpregna-1,4-diene-3,20-dioneChEBI
ClobetasolumChEBI
(11b,16b)-21-chloro-9-fluoro-11,17-Dihydroxy-16-methylpregna-1,4-diene-3,20-dioneGenerator
(11β,16β)-21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dioneGenerator
Clobetasol 17 propionateMeSH
Clobetasol 17-propionateMeSH
Clobetasol propionateMeSH
ClobexMeSH
ClofenazonMeSH
CormaxMeSH
DermovateMeSH
EmbelineMeSH
Embeline eMeSH
OLUXMeSH
TemovateMeSH
Chemical Formlia |
C22H28ClFO4
Average Molecliar Weight |
410.907
Monoisotopic Molecliar Weight |
410.166015296
IUPAC Name |
(1R,2S,10S,11S,13S,14R,15S,17S)-14-(2-chloroacetyl)-1-fluoro-14,17-dihydroxy-2,13,15-trimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-3,6-dien-5-one
Traditional Name |
clobetasol
CAS Registry Number |
25122-46-7
SMILES |
[H][C@@]12C[C@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
InChI Identifier |
InChI=1S/C22H28ClFO4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-17,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1
InChI Key |
FCSHDIVRCWTZOX-DVTGEIKXSA-N
Chemical Taxonomy |
Description |
This compound belongs to the class of chemical entities known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety.
Kingdom |
Chemical entities
Super Class |
Organic compounds
Class |
Lipids and lipid-like moleclies
Sub Class |
Steroids and steroid derivatives
Direct Parent |
Gluco/mineralocorticoids, progestogins and derivatives
Alternative Parents |
20-oxosteroids
11-beta-hydroxysteroids
17-hydroxysteroids
3-oxo delta-1,4-steroids
Halogenated steroids
Delta-1,4-steroids
Tertiary alcohols
Alpha-hydroxy ketones
Alpha-chloroketones
Secondary alcohols
Fluorohydrins
Cyclic ketones
Cyclic alcohols and derivatives
Alkyl fluorides
Alkyl chlorides
Hydrocarbon derivatives
Organic oxides
Organochlorides
Organofluorides
Substituents |
Progestogin-skeleton
20-oxosteroid
Hydroxysteroid
Halo-steroid
9-halo-steroid
Oxosteroid
11-beta-hydroxysteroid
11-hydroxysteroid
3-oxo-delta-1,4-steroid
3-oxosteroid
17-hydroxysteroid
Delta-1,4-steroid
Alpha-haloketone
Cyclic alcohol
Alpha-hydroxy ketone
Tertiary alcohol
Alpha-chloroketone
Cyclic ketone
Secondary alcohol
Fluorohydrin
Halohydrin
Ketone
Organooxygen compound
Alcohol
Organic oxide
Organic oxygen compound
Carbonyl group
Hydrocarbon derivative
Alkyl halide
Alkyl fluoride
Organofluoride
Organochloride
Organohalogen compound
Alkyl chloride
Aliphatic homopolycyclic compound
Molecliar Framework |
Aliphatic homopolycyclic compounds
External Descriptors |
11beta-hydroxy steroid (CHEBI:205919 )
17alpha-hydroxy steroid (CHEBI:205919 )
glucocorticoid (CHEBI:205919 )
20-oxo steroid (CHEBI:205919 )
fluorinated steroid (CHEBI:205919 )
3-oxo-Delta(1),Delta(4)-steroid (CHEBI:205919 )
chlorinated steroid (CHEBI:205919 )
Ontology |
Status |
Expected but not Quantified
Origin |
Drug
Biofunction |
Anti-inflammatory Agents
Cell signaling
Corticosteroids, topical
Fuel and energy storage
Fuel or energy source
Glucocorticoids
Membrane integrity/stability
Application |
Nutrients
Pharmaceutical
Stabilizers
Surfactants and Emlisifiers
Cellliar locations |
Cytoplasm
Extracellliar
Membrane
Physical Properties |
State |
Solid
Experimental Properties |
Property |
Value |
Reference |
Melting Point195.5 – 197 °CNot Available
Boiling PointNot AvailableNot Available
Water Solubility1.42e-02 g/LNot Available
LogP3Not Available
Predicted Properties |
Property |
Value |
Source |
Water Solubility0.014 mg/mLALOGPS
logP2.72ALOGPS
logP3.04ChemAxon
logS-4.5ALOGPS
pKa (Strongest Acidic)12.47ChemAxon
pKa (Strongest Basic)-3.4ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area74.6 Å2ChemAxon
Rotatable Bond Count2ChemAxon
Refractivity105.54 m3·mol-1ChemAxon
Polarizability41.97 Å3ChemAxon
Number of Rings4ChemAxon
Bioavailability1ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
Spectra |
Spectra |
Spectrum Type |
Description |
Splash Key |
|
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, NegativeNot Available
Biological Properties |
Cellliar Locations |
Cytoplasm
Extracellliar
Membrane
Biofluid Locations |
Blood
Urine
Tissue Location |
Not Available
Pathways |
Not Available
Normal Concentrations |
Biofluid |
Status |
Age |
Condition |
Reference |
Details |
BloodExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB01013
21059682
details
UrineExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB01013
21059682
details
|
Abnormal Concentrations |
|
Not Available
Associated Disorders and Diseases |
Disease References |
None
Associated OMIM IDs |
None
External Links |
DrugBank ID |
DB01013
DrugBank Metabolite ID |
Not Available
Phenol Explorer Compound ID |
Not Available
Phenol Explorer Metabolite ID |
Not Available
FoodDB ID |
Not Available
KNApSAcK ID |
Not Available
Chemspider ID |
4470588
KEGG Compound ID |
Not Available
BioCyc ID |
Not Available
BiGG ID |
Not Available
Wikipedia Link |
Clobetasol
NuGOwiki Link |
HMDB15148
Metagene Link |
HMDB15148
METLIN ID |
Not Available
PubChem Compound |
5311051
PDB ID |
Not Available
ChEBI ID |
205919
Product: THZ2 (Hydrochloride)
References |
Synthesis Reference |
Not Available |
Material Safety Data Sheet (MSDS) |
Not Available |
General References |
Not Available |
Enzymes
- General function:
- Involved in monooxygenase activity
- Specific function:
- Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.
- Gene Name:
- CYP1A1
- Uniprot ID:
- P04798
- Molecular weight:
- 58164.815
References
- Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- General function:
- Involved in monooxygenase activity
- Specific function:
- Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Most active in catalyzing 2-hydroxylation. Caffeine is metabolized primarily by cytochrome CYP1A2 in the liver through an initial N3-demethylation. Also acts in the metabolism of aflatoxin B1 and acetaminophen. Participates in the bioactivation of carcinogenic aromatic and heterocyclic amines. Catalizes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin.
- Gene Name:
- CYP1A2
- Uniprot ID:
- P05177
- Molecular weight:
- 58406.915
References
- Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
PMID: 11226258